Abstract

Activation of N-methyl-d-aspartate receptors (NMDARs) requires the binding of a coagonist, either d-serine or glycine, in addition to glutamate. Changes in occupancy of the coagonist binding site are proposed to modulate neural networks including those controlling swimming in frog tadpoles. Here, we characterize regulation of the NMDAR coagonist binding site in mammalian spinal locomotor networks. Blockade of NMDARs by d(-)-2-amino-5-phosphonopentanoic acid (d-APV) or 5,7-dichlorokynurenic acid reduced the frequency and amplitude of pharmacologically induced locomotor-related activity recorded from the ventral roots of spinal-cord preparations from neonatal mice. Furthermore, d-APV abolished synchronous activity induced by blockade of inhibitory transmission. These results demonstrate an important role for NMDARs in murine locomotor networks. Bath-applied d-serine enhanced the frequency of locomotor-related but not disinhibited bursting, indicating that coagonist binding sites are saturated during the latter but not the former mode of activity. Depletion of endogenous d-serine by d-amino acid oxidase or the serine-racemase inhibitor erythro-β-hydroxy-l-aspartic acid (HOAsp) increased the frequency of locomotor-related activity, whereas application of l-serine to enhance endogenous d-serine synthesis reduced burst frequency, suggesting a requirement for d-serine at a subset of synapses onto inhibitory interneurons. Consistent with this, HOAsp was ineffective during disinhibited activity. Bath-applied glycine (1-100 µM) failed to alter locomotor-related activity, whereas ALX 5407, a selective inhibitor of glycine transporter-1 (GlyT1), enhanced burst frequency, supporting a role for GlyT1 in NMDAR regulation. Together these findings indicate activity-dependent and synapse-specific regulation of the coagonist binding site within spinal locomotor networks, illustrating the importance of NMDAR regulation in shaping motor output.NEW & NOTEWORTHY We provide evidence that NMDARs within murine spinal locomotor networks determine the frequency and amplitude of ongoing locomotor-related activity in vitro and that NMDARs are regulated by d-serine and glycine in a synapse-specific and activity-dependent manner. In addition, glycine transporter-1 is shown to be an important regulator of NMDARs during locomotor-related activity. These results show how excitatory transmission can be tuned to diversify the output repertoire of spinal locomotor networks in mammals.

Highlights

  • NEW & NOTEWORTHY We provide evidence that NMDARs within murine spinal locomotor networks determine the frequency and amplitude of ongoing locomotor-related activity in vitro and that NMDARs are regulated by D-serine and glycine in a synapse-specific and activity-dependent manner

  • We provide evidence that both endogenous D-serine and glycine gate NMDARs within mammalian spinal networks to regulate the frequency of locomotor-related activity, that the NMDAR coagonist binding site at which they act is unsaturated during locomotor-related but saturated during disinhibited activity, and that the glycine transporter glycine transporter 1 (GlyT1) is a potent regulator of glycine concentration at excitatory synapses

  • These findings suggest that dynamic regulation of NMDARs via the coagonist binding site extends the output repertoire of mammalian spinal motor circuits, thereby facilitating appropriate behavior

Read more

Summary

Introduction

NEW & NOTEWORTHY We provide evidence that NMDARs within murine spinal locomotor networks determine the frequency and amplitude of ongoing locomotor-related activity in vitro and that NMDARs are regulated by D-serine and glycine in a synapse-specific and activity-dependent manner. Glycine transporter-1 is shown to be an important regulator of NMDARs during locomotorrelated activity These results show how excitatory transmission can be tuned to diversify the output repertoire of spinal locomotor networks in mammals. Concentrations of D-serine in the mammalian spinal cord are considerably lower than those of glycine, and much lower than those detected in the brain (Miyoshi et al 2012; Schell et al 1997; Sasabe et al 2007; Thompson et al 2012) On this basis, glycine was proposed as the exclusive coagonist of NMDARs www.jn.org

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call